Camlipixant

Camlipixant is an investigational new drug that has been evaluated for the treatment of chronic cough and irritable bowel syndrome.

Uses your system voice; voice and rate in settings.

≈ 1 min read

Cite, export and learn8 citation formats · 8 exports · lesson and quiz

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Camlipixant is an investigational new drug that has been evaluated for the treatment of chronic cough and irritable bowel syndrome. It is a P2X3 receptor antagonist. On July 17th 2026, GSK announced that the drug had failed to meet its primary endpoint in one of two phase 3 trials, and would be discontinuing development for chronic cough. The drug will continue to be investigated for use in irritable bowel syndrome.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1367448112 under CC BY-SA 4.0; modifications have been made.

Provenance

snapshot enwiki-001367448112 · captured 2026-08-03 · ledger · version history

Cite this page as: encyclopegia.org, “Camlipixant”, snapshot enwiki-001367448112. https://encyclopegia.org/a/camlipixant

Sources cited in this revision

4 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.